BSE Live
Mar 10, 12:04Prev. Close
4772.55
Open Price
4785.50
Bid Price (Qty.)
4804.05 (4)
Offer Price (Qty.)
4810.00 (11)
NSE Live
Mar 10, 12:04Prev. Close
4769.50
Open Price
4803.50
Bid Price (Qty.)
4806.50 (3)
Offer Price (Qty.)
4808.00 (11)
| Balance Sheet of Pfizer (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | |
| Total Share Capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | |
| Reserves and Surplus | 4,171.66 | 3,549.79 | 3,161.55 | 2,818.66 | 2,347.29 | |
| Total Reserves and Surplus | 4,171.66 | 3,549.79 | 3,161.55 | 2,818.66 | 2,347.29 | |
| Total Shareholders Funds | 4,217.41 | 3,595.54 | 3,207.30 | 2,864.41 | 2,393.04 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 67.62 | 54.35 | 93.32 | 127.74 | 42.68 | |
| Long Term Provisions | 56.57 | 32.33 | 42.76 | 55.47 | 55.84 | |
| Total Non-Current Liabilities | 124.19 | 86.68 | 136.08 | 183.21 | 98.52 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | |
| Trade Payables | 151.60 | 166.23 | 217.06 | 263.94 | 283.74 | |
| Other Current Liabilities | 364.07 | 332.85 | 337.27 | 507.90 | 407.47 | |
| Short Term Provisions | 51.34 | 44.98 | 100.52 | 78.55 | 80.63 | |
| Total Current Liabilities | 569.51 | 546.56 | 657.35 | 852.89 | 774.34 | |
| Total Capital And Liabilities | 4,911.11 | 4,228.78 | 4,000.73 | 3,900.51 | 3,265.90 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 171.82 | 150.95 | 177.53 | 218.92 | 192.38 | |
| Intangible Assets | 551.80 | 561.76 | 571.72 | 622.04 | 672.36 | |
| Capital Work-In-Progress | 7.64 | 0.40 | 7.93 | 1.15 | 2.76 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 28.17 | 29.56 | |
| Fixed Assets | 731.26 | 713.11 | 757.18 | 870.28 | 897.06 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 69.30 | 53.94 | 97.67 | 46.98 | 13.46 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.40 | 32.31 | |
| Other Non-Current Assets | 597.70 | 692.17 | 620.79 | 586.37 | 398.36 | |
| Total Non-Current Assets | 1,398.26 | 1,459.22 | 1,475.64 | 1,504.03 | 1,341.19 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 475.92 | 433.69 | 417.70 | 448.90 | 435.05 | |
| Trade Receivables | 193.09 | 187.61 | 151.73 | 124.27 | 129.69 | |
| Cash And Cash Equivalents | 2,800.98 | 2,046.71 | 1,859.52 | 1,633.33 | 1,115.10 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.26 | 8.56 | |
| OtherCurrentAssets | 42.86 | 101.55 | 96.14 | 189.72 | 236.31 | |
| Total Current Assets | 3,512.85 | 2,769.56 | 2,525.09 | 2,396.48 | 1,924.71 | |
| Total Assets | 4,911.11 | 4,228.78 | 4,000.73 | 3,900.51 | 3,265.90 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 364.73 | 533.83 | 437.83 | 338.14 | 254.98 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 596.03 | 520.19 | 0.84 | 0.00 | 0.51 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 113.99 | 84.76 | 68.78 | 78.13 | 33.92 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
10.02.2026
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011